Assembly Biosciences ASMB Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| —— | -$40.18M+34.4% | -$61.23M+34.2% | -$93.09M+28.3% | ||
| $129K0.0% | $129K-71.3% | $450K-9.6% | $498K+6.9% | ||
| $4.68M+49.9% | $3.12M-39.1% | $5.12M-22.4% | $6.59M+25.9% | ||
| $974K— | —— | -$944K— | —— | ||
| —— | —— | -$2.03M— | —— | ||
| —— | —— | —— | —— | ||
| $2.05M— | $0— | —— | -$814K+82.9% | ||
| -$36.1M— | —— | $83.56M— | —— | ||
| —— | -$51.12M-325% | $22.74M+127% | -$84.46M+9.6% | ||
| $66K— | —— | $255K+150% | $102K— | ||
| $229.83M+154% | $90.5M-32.4% | $133.92M+386% | $27.58M-82.8% | ||
| $116.43M-10.9% | $130.7M+101% | $65.02M+126% | $28.83M— | ||
| —— | —— | -$69.14M-176% | $90.64M— | ||
| —— | $2.03M— | —— | $325K-99.4% | ||
| $174.67M+493% | $29.45M+113% | $13.82M+2,150% | $614K-98.8% | ||
| $20.11M+8.7% | $18.5M— | —— | —— | ||
| $3K— | $0— | —— | —— | ||
| —— | —— | -$2.24M-705% | -$278K+75.0% | ||
| -$751K+46.4% | -$1.4M+62.9% | -$3.77M-2.8% | -$3.67M+3.1% | ||
| —— | —— | —— | —— | ||
| $2.05M— | —— | -$951K— | —— | ||
| $851K-39.9% | $1.42M-59.6% | $3.51M+0.1% | $3.51M-8.7% | ||
| $116.43M-10.9% | $130.7M+101% | $65.02M-26.1% | $88M-49.8% | ||
| $0-100% | $9.66M— | $0— | —— | ||
| $5.51M— | —— | —— | —— | ||
| -$36.1M— | —— | $83.56M— | —— | ||
| —— | -$51.15M-327% | $22.49M+127% | -$84.57M+12.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Assembly Biosciences generate?
- Assembly Biosciences (ASMB) generated -$77.4M in operating cash flow over the trailing twelve months.
- What is Assembly Biosciences's free cash flow?
- After $85.0K of capital expenditures, Assembly Biosciences's free cash flow was -$77.5M over the trailing twelve months, down 51.5% year over year.
- Where does Assembly Biosciences's cash flow data come from?
- Every line is extracted from Assembly Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
